The Cannabis and Psychedelics Investment Summit
A Family Office Series

September 20, 2022
BMA House
London, UK

Request Invitation

Request Sponsorship Info

Speakers

Join our industry experts, entrepreneurs, and investors as they discuss the critical topics investors should consider.

Edward Rees

Rees Family Office

Molly Maloof

Founder & CEO, Adamo Bioscience

Crispin Blunt

Member of Parliament of the United Kingdom

Bruce Linton

Entrepreneur and Investor

Claudia Mora

Managing Director, Black Legend Capital

Joel Sherlock

Co-Founder, Vitalis Extraction Tech

Mikael Sodergren

Sapphire Clinics

Julia Germaine

Operating Partner, KindRun

David Bonnier

Enexis AB

Kingsley Wilson

Partner, Chrystal Capital Partners

David Feldman

CEO & Co-Founder, Skip Intro

JJ McKay

Founder / Publisher, The Fresh Toast

Rob Sechrist

President, Pelorus Equity Group, Inc.

Kevin McGovern

McGovern Capital

Marco Hoffmann

Chief Executive Officer, SWISS Gate AG

Agenda

9:00am-10:00am

Breakfast, Registration & Mingling

10:00am-10:10am

MC Opening Remarks

10:10am-11:00am

An Overview of the Legal Cannabis and Psychedelic Industry

11:00am-11:40am

U.S. Markets

11:40am-12:10pm

European Medicinal cannabis

12:10pm-12:50pm

Investor Pitch Session

12:50pm-2:00pm

Networking Lunch

2:00pm-2:30pm

M&A and Capital Markets

2:30pm-3:10pm

The Benefits of an Investment Fund in The Cannabis Industry

3:10pm-3:30pm

Refreshment Break

3:30pm-4:00pm

Investing In Psychedelic Medicine

4:00pm-4:30pm

Investment 101 for Family Offices:

4:30pm-5:30pm

Cocktail Reception

Host Sponsor

Gold Sponsor

Silver Sponsor

Bronze Sponsors

Media Partners

PR Partner

Contact Us

This prestigious event will provide select sponsors an opportunity to interact with a curated group of hight net worth investors and family offices. For more info, please contact us at info@kahnerglobal.com or fill out the form below.

The Cannabis and Psychedelics Investment Summit A Family Office Series September 20, 2022 BMA House London, UK